Recent analyst actions from Seeking Alpha highlight a mixed picture across sectors, with notable upgrades for Bristol Myers Squibb (BMY) and Oracle (ORCL) alongside downgrades for Apple (AAPL) and Carvana (CVNA).
Bristol Myers To ensure this doesnât happen in the future, please enable Javascript and cookies in your browser
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. Entering text into the input field will update the search result below Entering text into the input field will update the search result below Quick Insights The analyst cites strong Q2 earnings, robust cash flow, undervaluation (forward P/E ~9.2x), an attractive dividend yield (~4%), and a promising late-stage pipeline with potential blockbuster assets.
Oracle’s upgrade is based on its leadership in sovereign air-gapped AI infrastructure and native agentic ERP applications, which provide a dual moat and long-term value potential. Apple was downgraded despite strong growth and earnings due to a stretched valuation (forward P/E of 38x vs. 5-year average of 29x) and a low shareholder yield (~2%), leading to a thin margin of safety